Piper Sandler Downgrades Collegium Pharmaceutical (COLL) to Neutral on Valuation
Tweet Send to a Friend
(Updated - May 10, 2024 8:13 AM EDT)
Piper Sandler analyst David Amsellem downgraded Collegium Pharmaceutical (NASDAQ: COLL) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Sandler analyst David Amsellem downgraded Collegium Pharmaceutical (NASDAQ: COLL) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
